FDA Approves MORPHINE SULFATE — Sun Pharmaceutical Industries, Inc.

Sun Pharmaceutical Industries, Inc. has secured approval for its generic morphine sulfate oral solution under ANDA078761, positioning the company to capitalize on market demand for this essential opioid analgesic. The greenlight enables the manufacturer to introduce competition to niche product formulations, potentially driving pricing pressures and improving patient access to long-duration pain relief alternatives.